Biomarker detection using TruSight® Oncology 500
/Melanoma is the third most common cancer in Australia, with an average of one person diagnosed every 30 minutes.
Read MoreMelanoma is the third most common cancer in Australia, with an average of one person diagnosed every 30 minutes.
Read MoreSince 2021, AGRF has been a key partner in the Zero Childhood Cancer Program (ZERO), Australia’s first precision medicine initiative for children with cancer. AGRF provides vital multi-omic sequencing data for each child, which helps inform personalised treatment plans.
Read MoreAGRF is partnering with SeonixBio to support the development and clinical implementation of a genetic risk prediction test for glaucoma. Assessing genetic risk of developing glaucoma will enable individuals to monitor for symptoms and make treatment decisions.
Read MoreAGRF plays a crucial role by providing genomic sequencing and analysis to patients with upcoming transplant procedures.
Read MoreEpigenetics is an exciting and rapidly expanding field in biology that has garnered interest in its applications to human health. It offers a promising approach to our understanding of how environmental factors can impact gene expression and contribute to the risk of chronic conditions.
Read MoreIn the field of genomics, researchers like Dr Amanda Duarte Barbosa are driven by an insatiable curiosity to unravel the mysteries held within the DNA of various organisms. A Senior Lecturer and Researcher at the Vector and Waterborne Pathogens Research Group, Murdoch University, WA, Amanda specialises in the molecular epidemiology of vector-borne pathogens that affect the animal-human-ecosystem interface, and it’s the enigmatic tick that has captured her attention.
Read MoreAssociate Professor Tu Nguyen-Dumont from Monash University. Associate Professor Tu Nguyen-Dumont serves as the genomics and bioinformatics lead in several multidisciplinary teams dedicated to exploring and defining genomic variations associated with cancer risk, cancer development, recurrence, and response to treatment.
Read MoreBacteria have long been a challenging adversary in the world of medicine. Antibiotics have been a primary treatment for bacterial infections, but their overuse has led to the emergence of antibiotic-resistant (AMR) bacteria, causing a significant health threat (refer health economics report commissioned by Iredell, Lin et al, Phage Australia). A promising revival of phage therapy is set to combat AMR infections more effectively and with fewer side effects than antibiotics.
Read MoreIn Australia, more than 1,000 children and adolescents are diagnosed with cancer every year. While the overall survival rate for childhood cancer is now over 80%, for some types of cancer the rate is much lower. Every week, three young lives are lost to cancer – more than to any other disease.
In 2021, AGRF joined a unique collaboration aiming to improve these statistics, becoming a key partner in the Zero Childhood Cancer Program (ZERO), Australia’s first national precision medicine program for children with cancer..
Learn how AGRF are helping to make a difference.
AGRF respectfully acknowledge the Aboriginal and Torres Straight Islander people as the Traditional Owners of the land on which we work and live, and we pay our respects to their Elders past and present.
We respect and recognise their continuing connection to Country and land, water and community.
AGRF Ltd.
ABN - 63 097 086 292